LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.

PHC

Plant Health Care Plc

9.475
0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 9.475 449 08:00:20
Bid Price Offer Price High Price Low Price Open Price
9.05 9.90
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pesticides, Agric Chems, Nec 8.43 -6.30 -2.10 - 29.08
Last Trade Time Trade Type Trade Size Trade Price Currency
11:27:46 O 101 9.0606 GBX

Plant Health Care (PHC) Latest News

Plant Health Care (PHC) Discussions and Chat

Plant Health Care (PHC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
10:27:469.061019.15O
08:58:179.05181.63O
07:00:219.0533029.87O
2023-06-01 14:17:599.841019.94O
2023-06-01 14:03:579.0580.72O

Plant Health Care (PHC) Top Chat Posts

Top Posts
Posted at 09/5/2023 12:08 by callumross
Comment: Whilst the Brazilian authorities do not commit to a specific timeline for granting regulatory licenses, Plant Health Care notes that it anticipates regulatory licenses will be granted within the next 1-2 years. We see this as conservative as looking back at the previous approval of PHC249 (Saori), the Brazilian authorities were relatively quick with their assessment and approvals, recognising the considerably lower risk profile of PREtec, enabling a federal registration for PHC279 in 10 months (March 2020 submission and January 2021 approval). With PHC249 and PHC949 coming from the same family of compounds (peptides), and with this prior track record, we would expect approval is received this year. This would enable a product launch in 2024 which would be in line with our forecasts. We look forward to the final registration/approval in due course this year and in the meantime, we maintain our Buy recommendation and 37p price target.
Posted at 02/5/2023 09:06 by pretax2
Not sure I completely understand the wobble here.
“The board is mindful of the impact to existing shareholders of any potential future equity raise at current share price levels”
Says the non-exec chairman, a man who holds more that 1% of the company’s shares, many in an ISA. Seems clear to me they’re trying to improve the status of the company whilst protecting shareholders.
‘If’ a reverse takeover occurs, this would by a quick and less expensive way to list on an exchange. It also increases liquidity (currently lacking for PHC) and increases the share price

Posted at 02/5/2023 08:42 by sidam
If Cenkos are correct, the fall in the share price appears ridiculous. They have reduced 2024 revenues by about 10% and projected a small profit. For 2025 the look for a PER of less than 3 at the current price and have a target of 37p. So, assuming Cenkos are correct and the share price is 9p, the shares will be profitable in the then current year and stand at next year’s PER of 3 when it is projected to still be growing at 30% for the next few years. I think their target is too low, but this could be a superb buying opportunity. The only problem appears to be the “consultation”.
Posted at 26/4/2023 12:33 by pretax2
If you don’t mind me giving my own 2.5p worth.
Both CR and JT have indicated that the share price should be higher. I asked CR why it was stagnating and he suggested that the company seemed to be viewed as a “show me” company. In other words show me that it works, show me that it sells, show me that you’re profitable. Up until last year I might have thought the same but things have fundamentally changed. PHC now has a suite of products; the products work brilliantly; revenue is growing towards profitability. But the big thing for me is climate change, energy change (biofuels), and a biblical food crisis. PHC have an answer for this - so the timing is right too.
I guess all great companies start small and investors end up regretting they didn’t buy the shares way back “then” when the share price was peanuts. Well for PHC, this is the ‘peanuts’; time when you should be buying. In my view, there is enormous upside to come with just 309m shares in issue, but no idea what’s going to shake Mr Market out of his manic-depression. Here’s a few possibilities though (just for fun).
1.Profitability (especially if earlier than expected).
2. Takeover talk. PHC has destribution deals with a number of monster companies. There are also some interesting connections with Syngenta.
3/ Premise: The need for consolidation in the sector is well known and it’s starting to happen. Second, PHC is an American company keen to engage American investors. If you’ll forgive my fight of fancy, how about a reverse takeover of an American ag-tech company? If that happened hold onto your eyebrows, PHC shares would supernova.
4/ No reason at all. Many companies breakout from their doldrums for no apparent reason. There’s just a move to a more realistic value that gets bought into by traders.
5/ Press article. To me PHC has a really exciting story. The right article in the right journal at the right time and bingo.

Posted at 26/4/2023 11:09 by oapknob1
Not well informed Callum. I continue to hold because the customer base is difficult to convert from current practice. The positive results from test fields and now Farmers in Brazil increasing yields/return per hectare and going to be the main influences to persuade other farmers of the benefits.An update on customer retention as well as growth would be a good indicator.An update on EU and US progress.You only have to look at the partners to see that when product sales do take off PHC will have significant market penetration through their partners.PepsiAgro are also viewing the testing in Mexico. A deal with them would be huge for PHC, if one were ever materialise. The Farming network they have and PHC fitting their greener production principles seems a good match IMO.
Posted at 26/4/2023 10:38 by callumross
Results next Tuesday, the main aspects of which have already been flagged up in the trading statement. Despite growth of turnover, product launches, reducing EBITDA loss and EBITDA positive forecast for next year, this share has treaded water for years. You seem to be well informed about PHC, OAP. Can you suggest what the drivers will be for long term appreciation in the share price since nothing seems to have driven it higher for the years I have held?
Posted at 24/4/2023 22:41 by oapknob1
Results for farmers using H2COPLA in Brazil have increased productivity per Hectare and boosted crop yields.Also coming to BrazilCombatting nematoids in a sustainable wayAccording to the article by √Črica Polo from @valoreconomico , losses caused by nematoids in different crops in Brazil result in an annual loss of R$ 65 billion, calculated in 2021. This alarming number has prompted an increase in nematicide use.In the past eight years, there has been a 10-fold increase in nematicide sales in Brazil. However, more and more biological defenses have stood out in the market.Since 2014/2015, chemical solutions accounted for 94% of the market. In the 21/22 crop, they reduced to 25%, leaving 75% of this market with organic. https://lnkd.in/dimXjTzU )Aware of the importance of this plague on the national market, Plant Health Care is bringing to the market its newest technology - the PHC68949 WP, a peptide from the T-REX platform aimed at the management of the nematoid of soybeans.When applied to seed treatment, the PHC68949 WP activates the soy defense system and allows for the reduction of eggs and adults in both root and soil tissues, resulting in significant increase in productivity.The PHC68949 WP is also being tested in different crops to face this important challenge which is the control of nematoids in agriculture, in a way that is sustainable to man and the environment.It's @plant_phcbrasil #breakingproductivitybarriers#agro #agroneg√≥cio #phc #PREtec #soja #bioinsumos #sustentabilidade
Posted at 18/1/2023 08:59 by pretax2
CR has said that they won’t accept a lowball offer. At the AGM there was mention of PHC being worth 20p and I’ve been interested to watch the share price make for the 10p range like a homing missile. I’m waiting for the RNS saying Syngenta are buying and the share price will supernova at that point. Hopefully beyond double. Sometimes I wonder if it’s all been worked out in advance; or maybe just my imagination!!!
Still, I’d prefer PHC to continue alone, given time this company could be great.

Posted at 22/7/2022 09:38 by blackswann
Hi, there were x2 lots of options granted at a 1p strike rateThe first batch of which there are just over 3m left.70% of these can be take if the share price AVERAGE over a 30 day period is 15p. The remaining 30% can be taken if the average share price over a 30 say period is 27p.The second batch of which there are just under 5m left.70% of these can be taken if the share price average over 30 days is 22p with the remaining available if share price average over 30 days hits 33p.Both batches expire in 2027.Options is one thing but proper skin in the game is the other. I like these a lot but the lack of director own money in is a bit of a ,let's say Amber flag. Not a red flag.A decent buy from a director at this level would complete the investment case for me and I would go all in. At present I think I'll scale in slowly just incase
Posted at 19/1/2022 17:51 by cerrito
Arden’s note on Research Tree a good summary pf the WE IMC meeting. It was good to hear that 279 will have a shelf life of 5 years; interested in the WE comment that these days a new product launch needs greater investment in time and effort than before and also that if a new product has not caught on after three years it never will.
Good that Arden’s forecast has $4m of cash at the end of 22 with no equity raises forecast for 22.
The PHC share price is suffering the same fate as my pre profit clean tech stocks such as CWR and ITM.

Plant Health Care share price data is direct from the London Stock Exchange
Your Recent History
LSE
PHC
Plant Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230602 11:30:25